Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jose, Rivas Rios"'
Autor:
Francesco Franchi, MD, Fabiana Rollini, MD, Victor Kairouz, MD, Jose Rivas Rios, MD, Andrea Rivas, MD, Malhar Agarwal, MD, Maryuri Briceno, MD, Mustafa Wali, MD, Ahmed Nawaz, MD, Gabriel Silva, MD, Zubair Shaikh, MD, Naji Maaliki, MD, Latonya Been, AAS, Jason Piraino, DPM, Andres M. Pineda, MD, Siva Suryadevara, MD, Daniel Soffer, MD, Martin M. Zenni, MD, Lisa K. Jennings, PhD, Theodore A. Bass, MD, Dominick J. Angiolillo, MD, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 4, Iss 7, Pp 763-775 (2019)
Summary: Vorapaxar reduces thrombotic cardiovascular events at the expense of increased bleeding. However, the differential pharmacodynamic (PD) effects of vorapaxar according to diabetes mellitus (DM) status are unknown. Moreover, although withdrawa
Externí odkaz:
https://doaj.org/article/b7ea15f9ac70419180a5ce0ec8e4c853
Autor:
Francesco Franchi, Dmitry M Yaranov, Fabiana Rollini, Andrea Rivas, Jose Rivas Rios, Latonya Been, Yuma Tani, Masaaki Tokuda, Tetsuo Iida, Noriko Hayashi, Dominick J Angiolillo, Arshag D Mooradian
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Current dietary guidelines recommend limiting sugar intake for the prevention of diabetes mellitus (DM). Reduction in sugar intake may require sugar substitutes. Among these, D-allulose is a non-calorie rare monosaccharide with 70% sweet
Externí odkaz:
https://doaj.org/article/7bfaccf322f74ea9976a9df0e0290edb
Autor:
Jose, Rivas Rios, Yi-Xin, Zhang, Melissa, Oye, Civan, Altunkaynak, Jinous, Saremian, Emil, Missov
Publikováno v:
Journal of geriatric cardiology : JGC. 19(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05124378d8ed03ffec2a1fcbb4d681ac
https://pubmed.ncbi.nlm.nih.gov/35572214
https://pubmed.ncbi.nlm.nih.gov/35572214
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e9f257af4a54a2e4f196722a5725cd4
https://doi.org/10.7759/cureus.23947
https://doi.org/10.7759/cureus.23947
Autor:
Tetsuo Iida, Dmitry M. Yaranov, Latonya Been, Masaaki Tokuda, Jose Rivas Rios, Dominick J. Angiolillo, Yuma Tani, Noriko Hayashi, Arshag D. Mooradian, Fabiana Rollini, Andrea Rivas, Francesco Franchi
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care
IntroductionCurrent dietary guidelines recommend limiting sugar intake for the prevention of diabetes mellitus (DM). Reduction in sugar intake may require sugar substitutes. Among these, D-allulose is a non-calorie rare monosaccharide with 70% sweetn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d0a23af1f5f71399ea2f3447d96745
https://drc.bmj.com/content/9/1/e001939.full
https://drc.bmj.com/content/9/1/e001939.full
Autor:
Malhar Agarwal, Naji Maaliki, Fabiana Rollini, Theodore A. Bass, Jose Rivas Rios, Siva Suryadevara, Gabriel Silva, Andres M. Pineda, Daniel Soffer, Lisa K. Jennings, Maryuri Briceno, Victor Kairouz, Andrea Rivas, Mustafa Wali, Francesco Franchi, Ahmed Nawaz, Dominick J. Angiolillo, Jason A. Piraino, Zubair Shaikh, Latonya Been, Martin M. Zenni
Publikováno v:
JACC: Basic to Translational Science, Vol 4, Iss 7, Pp 763-775 (2019)
Summary: Vorapaxar reduces thrombotic cardiovascular events at the expense of increased bleeding. However, the differential pharmacodynamic (PD) effects of vorapaxar according to diabetes mellitus (DM) status are unknown. Moreover, although withdrawa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761721f8088e6e0941192b82cd4d54b2
https://doi.org/10.1016/j.jacbts.2019.07.011
https://doi.org/10.1016/j.jacbts.2019.07.011
Autor:
Malhar Agarwal, Dmitry M. Yaranov, Latonya Been, Jose Rivas Rios, Maryuri Briceno, Victor Kairouz, Siva Suryadevara, Theodore A. Bass, Dominick J. Angiolillo, Fabiana Rollini, Francesco Franchi, Deepa Nagaraju, Daniel Soffer, Mustafa Wali, Megha Kureti, Martin M. Zenni, Emilio Garcia, Jae Youn Moon, Andrea Rivas
Publikováno v:
Thrombosis and Haemostasis. 120:083-093
In patients requiring dual antiplatelet therapy (DAPT) who also have an indication to be treated with oral anticoagulant (OAC) drugs, aspirin withdrawal reduces the risk of bleeding. There is limited data on the pharmacodynamic effects associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd472a0a4e5edb34c592721c5323dca5
https://doi.org/10.1055/s-0039-1695772
https://doi.org/10.1055/s-0039-1695772
Autor:
Dominick J. Angiolillo, Yongwhi Park, Megha Kureti, Jose Rivas Rios, Gabriel Faz, Theodore A. Bass, Andres M. Pineda, Francesco Franchi, Siva Suryadevara, Jenny Hu, Fabiana Rollini, Daniel Soffer, Dmitry M. Yaranov, Latonya Been, Martin M. Zenni
Publikováno v:
JACC: Cardiovascular Interventions. 12:1538-1549
Objectives The aim of this study was to assess if intravenous methylnaltrexone can counteract the effects of morphine on the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of ticagrelor. Background Morphine delays the onset of action of oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2850f23ac6da809f0300bf1d3dc6860
https://doi.org/10.1016/j.jcin.2019.05.028
https://doi.org/10.1016/j.jcin.2019.05.028
Publikováno v:
Cardiovascular Diagnosis and Therapy. 8:594-609
Diabetes mellitus (DM) is a metabolic disorder associated with accelerated atherogenesis and an increased risk of atherothrombotic complications. Multiple mechanisms contribute to the pro-thrombotic status which characterizes DM patients underscoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef3db8c27e9394086a5e2a30799de411
https://doi.org/10.21037/cdt.2018.05.09
https://doi.org/10.21037/cdt.2018.05.09
Autor:
Maryuri Briceno, Zubair Shaikh, Siva Suryadevara, Daniel Soffer, Theodore A. Bass, Dominick J. Angiolillo, Jae Youn Moon, Francesco Franchi, Ahmed Nawaz, Megha Kureti, Fabiana Rollini, Martin M. Zenni, Malhar Agarwal, Jose Rivas Rios, Andrea Rivas, Latonya Been, Deepa Nagaraju, Mustafa Wali
Publikováno v:
Circulation. 137:2450-2462
Background: Switching between different classes of P2Y 12 inhibitors, including de-escalation from ticagrelor to clopidogrel, commonly occurs in clinical practice. However, the pharmacodynamic profiles of this strategy have been poorly explored. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a417703dcb5a82c467d484fef4a292
https://doi.org/10.1161/circulationaha.118.033983
https://doi.org/10.1161/circulationaha.118.033983